Cardiff Oncology Inc.

NASDAQ: CRDF · Real-Time Price · USD
2.44
0.00 (0.00%)
At close: Aug 15, 2025, 1:09 PM

Cardiff Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-45.43M -41.44M -38.7M -28.29M
Depreciation & Amortization
404K 398K 236K 451K
Stock-Based Compensation
4.76M 4.51M 4.26M 3.23M
Other Working Capital
671K 3.25M -1.49M -2.29M
Other Non-Cash Items
-598K -921K 772K 2.03M
Deferred Income Tax
n/a n/a n/a 1.32M
Change in Working Capital
3.17M 6.57M -380K -1.79M
Operating Cash Flow
-37.69M -30.89M -33.82M -23.04M
Capital Expenditures
-80K -582K -892K -205K
Cash Acquisitions
n/a n/a -114K 205K
Purchase of Investments
-23.56M -70.08M -91.23M -174.38M
Sales Maturities Of Investments
37.37M 106.86M 130.27M 43.14M
Other Investing Acitivies
n/a n/a 114K -205K
Investing Cash Flow
13.73M 36.2M 38.15M -131.45M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a -414K -24K
Other Financial Acitivies
373K n/a 75K 1.29M
Financial Cash Flow
53.78M n/a 75K 35.45M
Net Cash Flow
29.82M 5.31M 4.4M -119.04M
Free Cash Flow
-37.77M -31.47M -34.71M -23.25M